Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product

News   Jan 19, 2009

 
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
 
 
 

RELATED ARTICLES

Radiographs of Dolly's Skeleton Show No Signs of Abnormal Osteoarthritis

News

Original concerns that cloning caused early-onset osteoarthritis (OA) in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.

READ MORE

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

Vaccine Against Diabetes Closer Than Ever

News

Scientists at the University of Tampere (Finland) and the Karolinska Institutet (Sweden) have demonstrated that an enterovirus vaccine can protect against virus-induced diabetes in a mouse model for Type 1 diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE